South Africa
7 Vaccines Approved for Use in South Africa
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: sahpra.org.za
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: forbes.com
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
6 trials in 1 country
Approval Source: indiatoday.in
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: reuters.com
Inactivated
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 6 countries
7 trials in 3 countries
Approval Source: seekingalpha.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: forbes.com
22 in Clinical Trials in South Africa
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
RNA
Pfizer/BioNTech
BNT162b2 (B.1.1.7)
RNA
Pfizer/BioNTech
BNT162b2 (B.1.1.7 + B.1.617.2)
RNA
Pfizer/BioNTech
BNT162b2 (B.1.617.2)
RNA
Providence Therapeutics Holdings Inc.
PTX-COVID19-B
4 trials in 2 countries
Non Replicating Viral Vector
ImmunityBio Inc
hAd5-Covid-19
7 trials in 2 countries
DNA
Scancell
COVIDITY
RNA
ImmunityBio Inc
AAHI-SC2 Vaccine
2 trials in 1 country
RNA
ImmunityBio Inc
AAHI-SC3 Vaccine
2 trials in 1 country
Protein Subunit
Clover
SCB-2019
15 trials in 13 countries
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 6 countries
7 trials in 3 countries
RNA
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1
Approved in 35 countries
3 trials in 5 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Protein Subunit
Clover
SCB-2020S
2 trials in 1 country
RNA
Gritstone bio, Inc.
GRT-R912
RNA
Gritstone bio, Inc.
GRT-R914
RNA
Gritstone bio, Inc.